1. Home
  2. GMED vs COKE Comparison

GMED vs COKE Comparison

Compare GMED & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • COKE
  • Stock Information
  • Founded
  • GMED 2003
  • COKE 1980
  • Country
  • GMED United States
  • COKE United States
  • Employees
  • GMED N/A
  • COKE 17000
  • Industry
  • GMED Medical/Dental Instruments
  • COKE Beverages (Production/Distribution)
  • Sector
  • GMED Health Care
  • COKE Consumer Staples
  • Exchange
  • GMED Nasdaq
  • COKE Nasdaq
  • Market Cap
  • GMED 11.6B
  • COKE 11.1B
  • IPO Year
  • GMED 2012
  • COKE N/A
  • Fundamental
  • Price
  • GMED $84.79
  • COKE $1,234.03
  • Analyst Decision
  • GMED Buy
  • COKE
  • Analyst Count
  • GMED 14
  • COKE 0
  • Target Price
  • GMED $90.69
  • COKE N/A
  • AVG Volume (30 Days)
  • GMED 822.2K
  • COKE 30.8K
  • Earning Date
  • GMED 11-05-2024
  • COKE 10-30-2024
  • Dividend Yield
  • GMED N/A
  • COKE 0.28%
  • EPS Growth
  • GMED N/A
  • COKE 19.88
  • EPS
  • GMED 0.67
  • COKE 57.53
  • Revenue
  • GMED $2,478,596,000.00
  • COKE $6,784,177,000.00
  • Revenue This Year
  • GMED $62.39
  • COKE N/A
  • Revenue Next Year
  • GMED $6.71
  • COKE N/A
  • P/E Ratio
  • GMED $124.29
  • COKE $22.01
  • Revenue Growth
  • GMED 102.10
  • COKE 2.86
  • 52 Week Low
  • GMED $49.33
  • COKE $800.76
  • 52 Week High
  • GMED $87.22
  • COKE $1,376.84
  • Technical
  • Relative Strength Index (RSI)
  • GMED 60.22
  • COKE 45.59
  • Support Level
  • GMED $81.42
  • COKE $1,273.99
  • Resistance Level
  • GMED $84.16
  • COKE $1,287.74
  • Average True Range (ATR)
  • GMED 1.70
  • COKE 23.60
  • MACD
  • GMED -0.40
  • COKE -5.42
  • Stochastic Oscillator
  • GMED 48.28
  • COKE 0.00

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc sells nonalcoholic beverage products in the United States. The company purchases concentrate and syrups from other beverage manufacturers under a license, then produces, packages, markets, and distributes the beverages to retailers. The company's primary licensor is Coca-Cola Co., which generally allows it to exclusively market, produce, and distribute Coca-Cola products in specified parts of the U.S.: North Carolina, South Carolina, West Virginia, and parts of Alabama, Georgia, Tennessee, Virginia, Indiana, and Kentucky. The company manages its business in two operating segments. Nonalcoholic Beverages segment which represents the majority of the company's revenues and All Other segments.

Share on Social Networks: